← Browse by Condition
Medical Condition

prostatic neoplasms castration resistant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07225946 Phase 3
Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Enrollment
800 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...
View Trial →